Related references
Note: Only part of the references are listed.Immunocapture strategies in translational proteomics
Claudia Fredolini et al.
EXPERT REVIEW OF PROTEOMICS (2016)
Proteomics Quality Control: Quality Control Software for MaxQuant Results
Chris Bielow et al.
JOURNAL OF PROTEOME RESEARCH (2016)
Peptide Patterns as Discriminating Biomarkers in Plasma of Patients With Familial Adenomatous Polyposis
Lisa Agatea et al.
CLINICAL COLORECTAL CANCER (2016)
Pathology of premalignant colorectal neoplasia
Joanna A. Gibson et al.
DIGESTIVE ENDOSCOPY (2016)
The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine
Shuji Ogino et al.
EPIDEMIOLOGY (2016)
Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives
Li Zhou et al.
EXPERT REVIEW OF PROTEOMICS (2016)
Recent advances in mass spectrometry analysis of histone post-translational modifications: potential clinical impact of the PAT-H-MS approach
Tiziana Bonaldi et al.
EXPERT REVIEW OF PROTEOMICS (2016)
Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis
Roi Villar-Vazquez et al.
PROTEOMICS (2016)
Progress in the development of protein biomarkers of oesophageal and gastric cancers
Caroline Coghlin et al.
PROTEOMICS CLINICAL APPLICATIONS (2016)
Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting
Hongda Chen et al.
ONCOTARGET (2016)
Identification of Predictive Markers for Response to Neoadjuvant Chemoradiation in Rectal Carcinomas by Proteomic Isotope Coded Protein Label (ICPL) Analysis
Roland S. Croner et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Proceedings of the second international molecular pathological epidemiology (MPE) meeting
Shuji Ogino et al.
CANCER CAUSES & CONTROL (2015)
MAPRE1 as a Plasma Biomarker for Early-Stage Colorectal Cancer and Adenomas
Ayumu Taguchi et al.
CANCER PREVENTION RESEARCH (2015)
LOXL2 Is Highly Expressed in Cancer-Associated Fibroblasts and Associates to Poor Colon Cancer Survival
Sofia Torres et al.
CLINICAL CANCER RESEARCH (2015)
Non-invasive prognostic protein biomarker signatures associated with colorectal cancer
Silvia Surinova et al.
EMBO MOLECULAR MEDICINE (2015)
Prediction of colorectal cancer diagnosis based oncirculating plasma proteins
Silvia Surinova et al.
EMBO MOLECULAR MEDICINE (2015)
Proteomic methods for biomarker discovery and validation. Are we there yet?
Yetrib Hathout
EXPERT REVIEW OF PROTEOMICS (2015)
Current strategies and findings in clinically relevant post-translational modification-specific proteomics
Oliver Pagel et al.
EXPERT REVIEW OF PROTEOMICS (2015)
Association Between Plasma Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal Cancer and Mortality
Raaj S. Mehta et al.
GASTROENTEROLOGY (2015)
Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology Approach
Moises Blanco-Calvo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Reproducible and Consistent Quantification of the Saccharomyces cerevisiae Proteome by SWATH-mass spectrometry
Nathalie Selevsek et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
Standardize antibodies used in research
Andrew Bradbury et al.
NATURE (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Biomarkers of colorectal cancer: Recent advances and future challenges
Caroline Coghlin et al.
PROTEOMICS CLINICAL APPLICATIONS (2015)
Reporting in studies of protein biomarkers of prognosis in colorectal cancer in relation to the REMARK guidelines
Lucy Jankova et al.
PROTEOMICS CLINICAL APPLICATIONS (2015)
Colorectal cancer
Ernst J. Kuipers et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
A mini review on cancer of unknown primary site: A clinical puzzle for the oncologists
Nicholas Pavlidis et al.
JOURNAL OF ADVANCED RESEARCH (2015)
The Role of SATB2 as a Diagnostic Marker for Tumors of Colorectal Origin
Anca Dragomir et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer
Petra Martin et al.
BMC CANCER (2014)
Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer
Hongda Chen et al.
CANCER LETTERS (2014)
Urinary PGE-M Levels Are Associated with Risk of Colorectal Adenomas and Chemopreventive Response to Anti-Inflammatory Drugs
Navya Bezawada et al.
CANCER PREVENTION RESEARCH (2014)
Urinary PGE-M in Colorectal Cancer: Predicting More than Risk?
Karen Colbert Maresso et al.
CANCER PREVENTION RESEARCH (2014)
Circulating pEGFR Is a Candidate Response Biomarker of Cetuximab Therapy in Colorectal Cancer
Theodora Katsila et al.
CLINICAL CANCER RESEARCH (2014)
End-binding protein 1 (EB1) up-regulation is an early event in colorectal carcinogenesis
Yolanda Stypula-Cyrus et al.
FEBS LETTERS (2014)
Unbiased Proteomic and Transcript Analyses Reveal that Stathmin-1 Silencing Inhibits Colorectal Cancer Metastasis and Sensitizes to 5-Fluorouracil Treatment
Wei Wu et al.
MOLECULAR CANCER RESEARCH (2014)
Garbage in, garbage out: A critical evaluation of strategies used for validation of immunohistochemical biomarkers
Gillian O'Hurley et al.
MOLECULAR ONCOLOGY (2014)
Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis
Federica Zoratto et al.
TUMOR BIOLOGY (2014)
Proteomics for discovery of candidate colorectal cancer biomarkers
Paula Alvarez-Chaver et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Challenges of Big Data analysis
Jianqing Fan et al.
NATIONAL SCIENCE REVIEW (2014)
Cancer of Unknown Primary Sites: What Radiologists Need to Know and What Oncologists Want to Know
Kyung Won Kim et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2013)
Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer
N. Snoeren et al.
BRITISH JOURNAL OF CANCER (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Next-generation sequencing in the clinic: Promises and challenges
Jiekun Xuan et al.
CANCER LETTERS (2013)
Plasma Adiponectin and Soluble Leptin Receptor and Risk of Colorectal Cancer: A Prospective Study
Mingyang Song et al.
CANCER PREVENTION RESEARCH (2013)
Lysyl Oxidase Plays a Critical Role in Endothelial Cell Stimulation to Drive Tumor Angiogenesis
Ann-Marie Baker et al.
CANCER RESEARCH (2013)
Proteomics in colorectal cancer translational research: Biomarker discovery for clinical applications
Meike de Wit et al.
CLINICAL BIOCHEMISTRY (2013)
The proteomics of formalin-fixed wax-embedded tissue
David Cilia Vincenti et al.
CLINICAL BIOCHEMISTRY (2013)
Management of the malignant colorectal polyp: ACPGBI position statement
J. G. Williams et al.
COLORECTAL DISEASE (2013)
Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention
Dora Colussi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease
Shuji Ogino et al.
MODERN PATHOLOGY (2013)
THE BIG CHALLENGES OF BIG DATA
Vivien Marx
NATURE (2013)
The progress of proteomic approaches in searching for cancer biomarkers
Nina Kocevar et al.
NEW BIOTECHNOLOGY (2013)
Identification of Kininogen-1 as a Serum Biomarker for the Early Detection of Advanced Colorectal Adenoma and Colorectal Cancer
Jing Wang et al.
PLOS ONE (2013)
Global Phosphotyrosine Proteomics Identifies PKCδ as a Marker of Responsiveness to Src Inhibition in Colorectal Cancer
Eliot T. McKinley et al.
PLOS ONE (2013)
Progress in the identification of plasma biomarkers of colorectal cancer
Caroline Coghlin et al.
PROTEOMICS (2013)
Proteomic and cytokine plasma biomarkers for predicting progression from colorectal adenoma to carcinoma in human patients
Jung-Won Choi et al.
PROTEOMICS (2013)
Nucleic Acids for Ultra-Sensitive Protein Detection
Kris P. F. Janssen et al.
SENSORS (2013)
A Machine-Learned Predictor of Colonic Polyps Based on Urinary Metabolomics
Roman Eisner et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Characterizing and measuring bias in sequence data
Michael G. Ross et al.
GENOME BIOLOGY (2013)
Epigenetics and Colorectal Cancer Pathogenesis
Kankana Bardhan et al.
Cancers (2013)
Urinary Prostaglandin E2 Metabolite and Risk for Colorectal Adenoma
Martha J. Shrubsole et al.
CANCER PREVENTION RESEARCH (2012)
Increased Plasma Levels of the APC-Interacting Protein MAPRE1, LRG1, and IGFBP2 Preceding a Diagnosis of Colorectal Cancer in Women
Jon J. Ladd et al.
CANCER PREVENTION RESEARCH (2012)
Proteomics of Bone and Soft Tissue Sarcomas
Sinclair R. Dundas et al.
Current Proteomics (2012)
Advances in the proteomic investigation of the cell secretome
Kristy J. Brown et al.
EXPERT REVIEW OF PROTEOMICS (2012)
Antibody validation by combining immunohistochemistry and protein extraction from formalin-fixed paraffin-embedded tissues
Claudia Schuster et al.
HISTOPATHOLOGY (2012)
Proteomic Analysis of Colorectal Cancer Metastasis: Stathmin-1 Revealed as a Player in Cancer Cell Migration and Prognostic Marker
Hwee Tong Tan et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Cancer of unknown primary site
Nicholas Pavlidis et al.
LANCET (2012)
Effect of Flexible Sigmoidoscopy-Based Screening on Incidence and Mortality of Colorectal Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
B. Joseph Elmunzer et al.
PLOS MEDICINE (2012)
SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas
Kristina Magnusson et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field
Shuji Ogino et al.
GUT (2011)
Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic Features
Erin S. O'Connor et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology
Phillip G. Febbo et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2011)
An Informatics-assisted Label-free Approach for Personalized Tissue Membrane Proteomics: Case Study on Colorectal Cancer
Chia-Li Han et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Serum Tests for Colorectal Cancer Screening
James Creeden et al.
MOLECULAR DIAGNOSIS & THERAPY (2011)
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial
Willem van Gijn et al.
LANCET ONCOLOGY (2011)
GENOMIC MEDICINE Genomics and the Continuum of Cancer Care
Ultan McDermott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Proteomics of Colorectal Cancer: Identification of a Protein Signature Associated with Prognosis
Donna O'Dwyer et al.
PLOS ONE (2011)
Improving Validation Practices in Omics Research
John P. A. Ioannidis et al.
SCIENCE (2011)
Mathematical Model Identifies Blood Biomarker-Based Early Cancer Detection Strategies and Limitations
Sharon S. Hori et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Maspin is a deoxycholate-inducible, anti-apoptotic stress-response protein differentially expressed during colon carcinogenesis
Claire M. Payne et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2011)
Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2010)
Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)
Stuart R. Cairns et al.
GUT (2010)
Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
Daniel J. Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A Cohort Study of STMN1 Expression in Colorectal Cancer: Body Mass Index and Prognosis
Shuji Ogino et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Eric Van Cutsem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): An update
Paul Hewitson et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis
Masako Nakanishi et al.
CANCER RESEARCH (2008)
Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot
Yinghua Qiu et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Urine PGE-M:: A metabolite of prostaglandin E2 as a potential biomarker of advanced colorectal neoplasia
J. Chad Johnson et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
LM McShane et al.
BRITISH JOURNAL OF CANCER (2005)
Share Paper
